Amgen (NASDAQ:AMGN) Raised to “Strong-Buy” at StockNews.com
Amgen (NASDAQ:AMGN – Get Free Report) was upgraded by StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Friday. AMGN has been the subject of a number of other research reports. TD Cowen boosted their target price on Amgen from $381.00 to $383.00 and gave […]
More Stories
Analyzing Mercury General (NYSE:MCY) & Deep Yellow (OTCMKTS:DYLLF)
Volatility & Risk Mercury General has a beta of 0.87, indicating that its stock price is 13% less volatile than...
Analyzing Mercury General (NYSE:MCY) & Deep Yellow (OTCMKTS:DYLLF)
Volatility & Risk Mercury General has a beta of 0.87, indicating that its stock price is 13% less volatile than...
Y-mAbs Therapeutics (NASDAQ:YMAB) Earns “Outperform” Rating from Wedbush
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research...
Y-mAbs Therapeutics (NASDAQ:YMAB) Earns “Outperform” Rating from Wedbush
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research...
VR Resources (CVE:VRR) Trading Down 16.7% – Here’s What Happened
VR Resources Ltd. (CVE:VRR – Get Free Report)’s share price traded down 16.7% during trading on Friday . The company...
VR Resources (CVE:VRR) Trading Down 16.7% – Here’s What Happened
VR Resources Ltd. (CVE:VRR – Get Free Report)’s share price traded down 16.7% during trading on Friday . The company...